MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop

J Exp Clin Cancer Res. 2018 Sep 25;37(1):238. doi: 10.1186/s13046-018-0879-z.

Abstract

Background: Aberrant activation of Wnt/β-catenin signaling pathway is considered to be an important issue in progression and metastasis of various human cancers, especially in colorectal cancer (CRC). MiR-452 could activate of Wnt/β-catenin signaling. But the mechanism remains unclear.

Methods: The expression of miR-452 in CRC and normal tissues was detected by real-time quantitative PCR. The effect of miR-452 on CRC growth and invasion was conducted by functional experiments in vitro and in vivo. Bioinformatics and cell luciferase function studies verified the direct regulation of miR-452 on the 3'-UTR of the GSK3β, which leads to the activation of Wnt/β-catenin signaling.

Results: MiR-452 was upregulated in CRC compared with normal tissues and was correlated with clinical significance. The luciferase reporter system studies affirmed the direct regulation of miR-452 on the 3'-UTR of the GSK3β, which activate the Wnt/β-catenin signaling. The ectopic upregulation of miR-452 significantly inhibited the expression of GSK3β and enhanced CRC proliferation and invasion in vitro and in vivo. Meanwhile, knockdown of miR-452 significantly recovered the expression of GSK3β and attenuated Wnt/β-catenin-mediated cell metastasis and proliferation. More important, T-cell factor/lymphoid enhancer factor (TCF/LEF) family of transcription factors, which are crucial downstream molecules of the Wnt/β-catenin signaling pathway was verified as a valid transcription factor of miR-452's promoter.

Conclusions: Our findings first demonstrate that miR-452-GSK3β-LEF1/TCF4 positive feedback loop induce CRC proliferation and migration.

Keywords: Colorectal caner; GSK3β; TCF4/LEF1; Wnt/β-catenin pathway; miR-452.

MeSH terms

  • Adult
  • Aged
  • Animals
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation / genetics*
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / pathology
  • Female
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques
  • Glycogen Synthase Kinase 3 beta / genetics*
  • HCT116 Cells
  • Humans
  • Lymphoid Enhancer-Binding Factor 1 / genetics
  • Male
  • Mice
  • MicroRNAs / genetics*
  • Middle Aged
  • Neoplasm Staging
  • Phenotype
  • Promoter Regions, Genetic
  • Transcription Factor 4 / genetics
  • Wnt Signaling Pathway / genetics
  • Xenograft Model Antitumor Assays

Substances

  • LEF1 protein, human
  • Lymphoid Enhancer-Binding Factor 1
  • MIRN452 microRNA, human
  • MicroRNAs
  • TCF4 protein, human
  • Transcription Factor 4
  • Glycogen Synthase Kinase 3 beta